Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Edwards’ Sapien sales spike 67% during 1st quarter on U.S. market
Shares of Edwards Lifesciences jump 4% in after-hours trading after the company posts a 67% spike in Q1 Sapien transcatheter heart valve sales.
2. NASDAQ halts trading in HeartWare shares ahead of FDA panel vote
The NASDAQ stock exchange halts trading in shares of HeartWare International ahead of an FDA panel vote on its pre-market approval application for an implantable heart pump.
1. Senate panel adds safety measures to FDA user fee act
The U.S. Senate’s Health, Education, Labor & Pensions Committee passes the "Food & Drug Administration Safety and Innovation Act," but fails to include provisions consumer advocates insist are necessary to protect patients from unsafe medical devices.
